News tagged with cancer chemotherapy
Weekly dose reduces targeted drug's side effects, but not its activity against ALL
A potent chemotherapy agent wrapped within a monoclonal antibody selectively destroys the malignant cells responsible for acute lymphocytic leukemia (ALL) in either weekly or monthly dosing, researchers report at the 54th ...
Cancer
Dec 11, 2012 |
not rated yet |
0
FDA OKs expanded use of prostate cancer drug
(HealthDay)—The approved use of the drug Zytiga has been expanded to include treatment of men with late-stage, hormone therapy-resistant prostate cancer before they undergo chemotherapy, the U.S. Food ...
Medications
Dec 10, 2012 |
not rated yet |
0
Novel drug therapy targets aggressive form of non-Hodgkin's lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell – DLBCL ...
Cancer
Dec 10, 2012 |
not rated yet |
0
|
Scientists identify liposarcoma tumors that respond to chemotherapy
Liposarcoma, the most common type of sarcoma, is an often lethal form of cancer that develops in fat cells. It is particularly deadly, in part, because the tumors are not consistently visible with positron emission tomography ...
Cancer
Dec 10, 2012 |
not rated yet |
0
Stem cell research provides hope for infertile cancer survivors
Radiation and chemotherapy can pack a powerful punch against all kinds of cancers. Those who survive, however, are often left with bad news: Their treatments have rendered them infertile.
Medical research
Dec 10, 2012 |
not rated yet |
0
Pre-clinical data shows Angiocidin effective against leukemia
Angiocidin, a novel tumor-inhibiting protein, has been shown to reduce acute myeloid leukemia (AML) cells in vivo by almost two-thirds in pre-clinical experiments.
Cancer
Dec 09, 2012 |
not rated yet |
0
Genetic susceptibility to anthracycline-related congestive heart failure (CHF) in survivors of hematopoietic cell transp
Researchers have identified specific genetic factors that are associated with heart failure in patients who have undergone hematopoietic stem cell transplantation (HCT) for blood cancer.
Medical research
Dec 09, 2012 |
not rated yet |
0
'Chemo brain' may occur before treatment even starts
(HealthDay)—So-called "chemo brain"—problems with thinking, concentrating and remembering that are associated with receiving chemotherapy—may actually start to occur before the treatment is initiated, ...
Cancer
Dec 07, 2012 |
5 / 5 (1) |
0
Study compares standard against newer treatment in women whose breast cancer has spread
Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, ...
Cancer
Dec 07, 2012 |
not rated yet |
0
Diverse genetic alterations found in triple-negative breast cancers after neoadjuvant chemotherapy
Many different genetic alterations were detected in tumor cells left behind after patients with triple-negative breast cancer were treated with chemotherapy prior to surgery (neoadjuvant chemotherapy), according to data presented ...
Cancer
Dec 07, 2012 |
not rated yet |
0
|
Chemo may extend survival after breast cancer's return
(HealthDay)—In women with breast cancer that has recurred but remains confined to in or near the breast, post-surgical chemotherapy appears to boost survival, new research shows.
Cancer
Dec 06, 2012 |
not rated yet |
0
Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
Most patients whose breast cancer has spread to their lymph nodes have most of the lymph nodes in their armpit area removed after chemotherapy to see if any cancer remains. A study conducted through the American College of ...
Cancer
Dec 05, 2012 |
not rated yet |
0
Longer life expectancy, aging population necessitate new strategies for prostate cancer care
The population of the United States is getting older, due not only to aging boomers but also to a four-year increase in life expectancy from 1990 to 2010. An aging population means increased diagnosis of prostate cancer. ...
Cancer
Dec 04, 2012 |
not rated yet |
0
Improving chemotherapy effectiveness by acting on the immune system
An Inserm team in Dijon directed by François Ghiringhelli is to publish an article this week in the Nature Medicine review. The article suggests that two chemotherapy drugs frequently used to treat digestive and breast cancers ...
Immunology
Dec 04, 2012 |
not rated yet |
0
Treating childhood cancer in developing countries less expensive than believed
(Medical Xpress)—The assumption that childhood cancer in developing countries is prohibitively expensive to treat is challenged by new research contributed to by the University of Sydney.
Cancer
Dec 03, 2012 |
not rated yet |
0
